Tonix Pharmaceuticals 的股价飙升了 54.5%，尽管 StockNews.com 给出了“卖出”评级。 Tonix Pharmaceuticals' stock surged 54.5%, despite a "sell" rating from StockNews.com.

Tonix Pharmaceuticals 的股价周四飙升 54.5%，收于 16.93 美元，交易量增长 1,096%。 Tonix Pharmaceuticals' stock soared 54.5% on Thursday, closing at $16.93 with trading volume up 1,096%. 尽管价格飙升，StockNews.com 还是给出了“卖出”评级。 Despite the surge, StockNews.com issued a "sell" rating. 该公司开发治疗人类疾病的药物,机构投资者增加了投资。 The company, which develops therapeutics for human diseases, has seen institutional investors increase their stakes. Tonix的市场上限为2 779万美元,高贝塔为2.07,表明波动性很大。 Tonix has a market cap of $27.79 million and a high beta of 2.07, indicating high volatility.